Europäische Marktprognose für Strahlenonkologie bis 2031 – Regionale Analyse – nach Typ (externe Strahlentherapie und interne Strahlentherapie) und Anwendung (Brustkrebs, Prostatakrebs, Lungenkrebs, Kopf- und Halskrebs, Gebärmutterhalskrebs und andere)
Initiativen zur Unterstützung der Entwicklung in der Strahlenonkologie treiben den europäischen Markt für Strahlenonkologie an
Die Regierungen und Organisationen führen Missionen und Programme zur schnellen und wirksamen Behandlung von Krebs mittels Strahlentherapie ein. Im September 2023 kündigte die Internationale Atomenergie-Organisation (IAEA) die „Rays of Hope“-Flaggschiff-Krebsinitiative zur Entwicklung der Infrastruktur für Strahlentherapie an. In Industrieländern wie den USA, Deutschland, Großbritannien, Frankreich und anderen haben fast alle Patienten Zugang zu Strahlentherapie. In Ländern mit mittlerem Einkommen haben 60 % der Patienten und 1 von 10 Patienten in Ländern mit niedrigem Einkommen Zugang zu Strahlentherapie. „Rays of Hope Cancer Care for All“ konzentriert sich auf die Entwicklung von Strahlentherapiediensten auf der ganzen Welt. Seit dem Start der Initiative haben verschiedene Länder Strahlentherapiegeräte und die erforderliche Ausbildung für den Betrieb der Geräte zur rechtzeitigen Diagnose und Behandlung erhalten. Alle fünf Kontinente sind an der Initiative beteiligt und haben 45,5 Millionen US-Dollar (42 Millionen Euro) zur Unterstützung beigetragen, und der private Sektor hat 768.902 US-Dollar (710.000 Euro) zur Unterstützung investiert. Darüber hinaus haben Hersteller wie Elekta eine Partnerschaft mit der IAEA zur Verbesserung der Krebsbehandlung unterzeichnet, indem sie Strahlentherapiegeräte auf der ganzen Welt bereitstellen. Darüber hinaus hat die IAEA mit der Ausbildung von Gesundheitsfachkräften aus verschiedenen Bereichen begonnen, darunter 14 Strahlenonkologen, 13 Medizinphysiker, 4 Nuklearmedizintechniker, 7 Nuklearmediziner, 7 Radiopharmazeuten, 16 Strahlentherapietechniker, 7 Onkologiekrankenpfleger, 4 Medizintechniker für Bildgebung und 7 Radiologen. Daher ist zu erwarten, dass die zunehmenden Initiativen für die Strahlentherapie die Verbreitung in Ländern mit niedrigem Einkommen erhöhen werden. Außerdem werden ausgebildete Fachkräfte und die Entwicklung der Infrastruktur für die Strahlentherapie das Wachstum des Marktes für Strahlenonkologie in den kommenden Jahren vorantreiben.
Überblick über den europäischen Markt für Strahlenonkologie
Deutschland verfügt über eine fortschrittliche Gesundheitsinfrastruktur mit Zugang zu Spitzentechnologien, die die Durchführung von Strahlentherapieverfahren unterstützen. Das Land ist auch für seinen starken Schwerpunkt auf Innovation und Forschung bekannt. In Deutschland tätige umfassende Krebszentren bieten multidisziplinäre Behandlungspläne an, die Strahlentherapie, Chirurgie, Chemotherapie und andere medizinische Verfahren umfassen. Im Jahr 2020 gab Varian bekannt, dass das Deutsche Krebsforschungszentrum (DKFZ) in Heidelberg eine Adaptive Intelligence-Lösung bestellt hat, die erste Ethos-Therapie im Land. Diese KI-gestützte, allumfassende Lösung zielt darauf ab, die Wirksamkeit, Anpassungsfähigkeit und Kapazität der Strahlentherapie zu verbessern.
Umsatz und Prognose des europäischen Marktes für Strahlenonkologie bis 2031 (Mio. USD)
Segmentierung des europäischen Marktes für Strahlenonkologie
Der europäische Markt für Strahlenonkologie ist nach Typen, Anwendung und Land unterteilt.
Basierend auf dem Typ ist der europäische Markt für Strahlenonkologie in externe Strahlentherapie und interne Strahlentherapie unterteilt. Das Segment der externen Strahlentherapie hatte 2023 einen größeren Marktanteil.
In Bezug auf die Anwendung ist der europäische Markt für Strahlenonkologie in Brustkrebs, Prostatakrebs, Lungenkrebs, Kopf- und Halskrebs, Gebärmutterhalskrebs und andere unterteilt. Das Segment Brustkrebs hatte 2023 den größten Marktanteil.
Nach Ländern ist der europäische Markt für Strahlenonkologie in Deutschland, Großbritannien, Frankreich, Spanien, Italien und den Rest von Europa unterteilt. Deutschland dominierte 2023 den europäischen Markt für Strahlenonkologie.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc und Curium sind einige der führenden Unternehmen auf dem europäischen Markt für Strahlenonkologie.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Radiation Oncology Market - Key Market Dynamics
4.1 Market Drivers:
4.1.1 Increasing Prevalence of Cancer
4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:
5. Radiation Oncology Market - Europe Market Analysis
5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
6. Europe Radiation Oncology Market Analysis - by Types
6.1 External Beam Radiation Therapy
6.1.1 Overview
6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
6.2.1 Overview
6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7. Europe Radiation Oncology Market Analysis - by Application
7.1 Breast Cancer
7.1.1 Overview
7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
7.2.1 Overview
7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
7.3.1 Overview
7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
7.4.1 Overview
7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
7.5.1 Overview
7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. Europe Radiation Oncology Market - Country Analysis
8.1 Europe
8.1.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
8.1.1.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.1.1 Germany: Radiation Oncology Market Breakdown, by Types
8.1.1.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.1.4 Germany: Radiation Oncology Market Breakdown, by Application
8.1.1.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
8.1.1.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
8.1.1.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.3.1 France: Radiation Oncology Market Breakdown, by Types
8.1.1.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.3.4 France: Radiation Oncology Market Breakdown, by Application
8.1.1.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 Spain: Radiation Oncology Market Breakdown, by Types
8.1.1.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.4.4 Spain: Radiation Oncology Market Breakdown, by Application
8.1.1.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.5.1 Italy: Radiation Oncology Market Breakdown, by Types
8.1.1.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.5.4 Italy: Radiation Oncology Market Breakdown, by Application
8.1.1.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
8.1.1.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
9. Radiation Oncology Market - Industry Landscape
9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Varian Medical Systems Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview (Siemens Healthineers AG)
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Elekta AB
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Accuray Incorporated
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Becton Dickinson and Co
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Nordion
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Mevion Medical Systems
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 NTP RADIOISOTOPES
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Mallinckrodt Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Curium
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Radiation Oncology Market Segmentation
Table 2. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 15. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 16. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 17. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 19. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 20. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 21. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 22. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 24. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 25. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 28. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. Europe Radiation Oncology Market Segmentation, by Country
Figure 2. Radiation Oncology Market - Key Market Dynamics
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Europe Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 17. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 19. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated.
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Nordion.
- Mevion Medical Systems.
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.